Author:
Srivastava Shashikant,van Zyl Johanna,Cirrincione Kayle,Martin Katherine,Thomas Tania,Deshpande Devyani,Alffenaar Jan-William,Seddon James A.,Gumbo Tawanda
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health
Reference35 articles.
1. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.;Dheda;Lancet Respir Med,2017
2. FDA approval of bedaquiline – the benefit-risk balance for drug-resistant tuberculosis.;Cox;N Engl J Med,2014
3. Delamanid for multidrug-resistant pulmonary tuberculosis.;Gler;N Engl J Med,2012
4. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis.;Bloemberg;N Engl J Med,2015
5. Delamanid and bedaquiline resistance in Mycobacterium tuberculosis ancestral Beijing genotype causing extensively drug-resistant tuberculosis in a Tibetan refugee.;Hoffmann;Am J Respir Crit Care Med,2016
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献